Kimberly-Clark Acquires Kenvue in $49 Billion Deal
Consumer giant Kimberly-Clark, maker of Huggies diapers and Kleenex tissues, is buying Kenvue, the company behind Tylenol and Band-Aids, in a $49 billion merger.
The deal comes amidst controversy surrounding Tylenol, after the Trump administration linked its active ingredient, acetaminophen, to autism, despite lacking clear scientific evidence. Kenvue has denounced these claims as "simply false".
- Tylenol
- Band-Aids
- Listerine
- Neutrogena
- Aveeno
the two "iconic companies" would create "a global health and wellness leader" - Mike Hsu, Kimberly-Clark CEO
Author's summary: Kimberly-Clark buys Kenvue for $49 billion.
More News
- The legitimacy trap: How international institutions sustain the Houthis' hold on Yemen
- Could Zohran Mamdani's policies provide a template for other American cities? - Monocle
- Previewing the 2025 MIAA Football Tournaments | WATD 95.9 FM
- Opinion: Governor’s early Christmas spirit is misplaced | Peninsula Clarion